Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1975 Aug;51(598):512–514. doi: 10.1136/pgmj.51.598.512

Renal failure in obstructive jaundice—pathogenic factors

E N Wardle
PMCID: PMC2496280  PMID: 1234333

Abstract

In the patient with obstructive jaundice, preliminary dehydration, combined with the toxic effects of free bilirubin and serum bile acids, together with factors which cause inhibition of fibrinolysis, determine a high degree of renal susceptibility to ischaemia. Evidence from animals and man suggests that intravascular coagulation determined by endotoxaemia from the obstructed biliary system occurs at the onset of acute renal failure. Endotoxin is unique in being able to produce all those factors which separately cause a primary increase of renal arteriolar constriction.

Full text

PDF
512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoyagi T., Lowenstein L. M. The effect of bile acids and renal ischemia on renal function. J Lab Clin Med. 1968 Apr;71(4):686–692. [PubMed] [Google Scholar]
  2. Baum M., Stirling G. A., Dawson J. L. Further study into obstructive jaundice and ischaemic renal damage. Br Med J. 1969 Apr 26;2(5651):229–231. doi: 10.1136/bmj.2.5651.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergstein J. M., Michael A. F., Jr Failure of cobra venom factor to prevent the generalized Shwartzman reaction and loss of renal cortical fibrinolytic activity. Am J Pathol. 1974 Jan;74(1):19–31. [PMC free article] [PubMed] [Google Scholar]
  4. Cowger M. L., Igo R. P., Labbe R. F. The mechanism of bilirubin toxicity studied with purified respiratory enzyme and tissue culture systems. Biochemistry. 1965 Dec;4(12):2763–2770. doi: 10.1021/bi00888a029. [DOI] [PubMed] [Google Scholar]
  5. Farrar W. E., Jr, Corwin L. M. The essential role of the liver in detoxification of endotoxin. Ann N Y Acad Sci. 1966 Jun 30;133(2):668–684. doi: 10.1111/j.1749-6632.1966.tb52397.x. [DOI] [PubMed] [Google Scholar]
  6. Fulop M., Katz S., Lawrence C. Extreme hyperbilirubinemia. Arch Intern Med. 1971 Feb;127(2):254–258. [PubMed] [Google Scholar]
  7. Fulop M., Sandson J. The effect of bile salts on the binding of bilirubin by plasma proteins. Clin Sci. 1967 Dec;33(3):459–469. [PubMed] [Google Scholar]
  8. Greisman S. E., Woodward C. L. Mechanisms of endotoxin tolerance. VII. The role of the liver. J Immunol. 1970 Dec;105(6):1468–1476. [PubMed] [Google Scholar]
  9. Johnson K. J., Ward P. A. The requirement for serum complement in the detoxification of bacterial endotoxin. J Immunol. 1972 Mar;108(3):611–616. [PubMed] [Google Scholar]
  10. SCHAFFNER F., POPPER H., STEIGMANN F. The significance of bilirubin partition in hepatobiliary diseases. Am J Med Sci. 1950 Mar;219(3):307–315. doi: 10.1097/00000441-195003000-00009. [DOI] [PubMed] [Google Scholar]
  11. Skarnes R. C. Host defense against bacterial endotoxemia: mechanism in normal animals. J Exp Med. 1970 Aug 1;132(2):300–316. doi: 10.1084/jem.132.2.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Topuzlu C., Stahl W. M. Effect of bile infusion on the dog kidney. N Engl J Med. 1966 Apr 7;274(14):760–763. doi: 10.1056/NEJM196604072741402. [DOI] [PubMed] [Google Scholar]
  13. WATERLOW J. Liver choline-esterase in malnourished infants. Lancet. 1950 May 13;1(6611):908–909. doi: 10.1016/s0140-6736(50)90738-0. [DOI] [PubMed] [Google Scholar]
  14. Wardle E. N. Fibrinogen in liver disease. Arch Surg. 1974 Dec;109(6):741–746. doi: 10.1001/archsurg.1974.01360060011003. [DOI] [PubMed] [Google Scholar]
  15. Wardle E. N., Wright N. A. Endotoxin and acute renal failure associated with obstructive jaundice. Br Med J. 1970 Nov 21;4(5733):472–474. doi: 10.1136/bmj.4.5733.472. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES